WallStreetZenWallStreetZen

NYSEMKT: IBO
Impact Biomedical Inc Stock Ownership - Who owns Impact Biomedical?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Impact Biomedical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christian Thomas ZimmermanDirector2026-10-074,170$4.54
$18.93kSell
Heng Fai Ambrose ChanDirector2026-10-074,170$4.54
$18.93kSell
Castel Berisford HibbertDirector2026-10-074,170$4.54
$18.93kSell
David K. KeeneDirector2026-10-074,170$4.54
$18.93kSell
Todd D. MacKoCFO2026-10-074,170$4.54
$18.93kSell
Melissa Kaye SimsDirector2026-10-074,170$4.54
$18.93kSell
Mark SuseckCOO2026-10-074,170$4.54
$18.93kSell
Elise BrownellDirector2026-10-074,170$4.54
$18.93kSell
Jason GradyDirector2026-10-074,170$4.54
$18.93kSell
Dss Inc10% Owner2026-09-24156$7.06
$1.10kSell

1 of 2

IBO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IBO insiders and whales buy or sell their stock.

IBO Shareholders

What type of owners hold Impact Biomedical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dss Inc30.11%2,601,400$12.02MInsider
Frank D. Heuszel1.13%97,344$449.73kInsider
Heng Fai Ambrose Chan0.37%32,112$148.36kInsider
Elise Brownell0.37%32,112$148.36kInsider
David K. Keene0.37%32,112$148.36kInsider
Melissa Kaye Sims0.37%32,112$148.36kInsider
Christian Thomas Zimmerman0.37%32,112$148.36kInsider
Mark Suseck0.37%32,112$148.36kInsider
Castel Berisford Hibbert0.37%32,112$148.36kInsider
Jason Grady0.33%28,164$130.12kInsider

1 of 3

IBO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBO0.04%34.35%Net SellingNet Selling
EXOZ0.00%100.00%Net BuyingNet Buying
LONA0.05%99.95%Net BuyingNet Buying
VERU0.01%99.99%Net BuyingNet Buying
ANVS0.03%24.08%Net BuyingNet Buying
View Top Biotech Stocks

Impact Biomedical Stock Ownership FAQ

Who owns Impact Biomedical?

Impact Biomedical (NYSEMKT: IBO) is owned by 0.04% institutional shareholders, 34.35% Impact Biomedical insiders, and 65.60% retail investors. Dss Inc is the largest individual Impact Biomedical shareholder, owning 2.60M shares representing 30.11% of the company. Dss Inc's Impact Biomedical shares are currently valued at $11.19M.

If you're new to stock investing, here's how to buy Impact Biomedical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.